Stem Cell Therapies for Intracerebral Hemorrhages

Area of Science:

• Regenerative Medicine
• Neurology
• Biomedical Engineering

Background:

• Intracerebral hemorrhage (ICH) poses a critical threat to patients, highlighting the urgent need for effective treatment breakthroughs.
• While stem cell therapies have advanced for ischemic stroke, their application and research for ICH have lagged.

Purpose of the Study:

• To review the current state of stem cell treatments for intracerebral hemorrhage (ICH).
• To explore experimental models, medical care, and emerging stem cell therapies for ICH.
• To discuss future prospects for stem cell-based ICH treatment.

Main Methods:

• Systematic review of recent literature on stem cell therapies for ICH.
• Analysis of experimental models used in ICH research.
• Examination of current medical care and proposed stem cell treatment strategies.

Main Results:

• Stem cell therapy has demonstrated efficacy in preclinical models (rodents and animals) of ICH.
• Limited but promising clinical trials in humans have shown significant functional recovery.
• Current research indicates potential for stem cells to mitigate ICH-induced brain injury.

Conclusions:

• Understanding the precise mechanisms of stem cell therapy in ICH is crucial.
• Development of reliable and definitive treatment strategies is required for clinical application.
• A variety of stem cell types are expected to become available for future ICH treatment.